Psychopharmacology and Psychiatry Updates – Details, episodes & analysis

In this episode, we explore a groundbreaking study on escitalopram's efficacy in treating generalized anxiety disorder in children and adolescents. We discuss its potential as the first FDA-approved medication for youth anxiety. How might this change our approach to pediatric anxiety treatment?

Faculty: David Rosenberg, M.D.
Host: Richard Seeber, M.D.

• Learn more about our membership here
• Earn 0.5 CMEs: CAP Smart Takes Vol. 18
• The Role of Escitalopram in Treating Generalized Anxiety Disorder in Youth

In this episode, we explore psychodynamic psychopharmacology and its role in addressing treatment-resistant cases. We discuss how patient-doctor relationships, transference, and countertransference can impact medication effectiveness. How might your own unconscious biases influence your prescribing decisions?

Faculty: David Mintz, M.D.
Host: Richard Seeber, M.D.

• Learn more about our memberships here
• Earn 1.75 CME: Psychodynamic Psychopharmacology: From Biomedical Approaches to Patient Relationships
• Cultivating a Therapeutic Alliance

In this episode, we explore the latest pharmacologic interventions for managing insomnia in patients with major depressive disorder. Can dual orexin receptor antagonists, melatonin agonists, and low-dose doxepin provide relief for those struggling with sleep? Join us as we discuss the advances in treating insomnia and depression.

Faculty: Amit Chopra, M.D.
Host: Richard Seeber, M.D.

• Learn more about our memberships here
• Earn 1.25 CMEs: Navigating Insomnia in Major Depressive Disorder: Advances in Management
• Other Pharmacologic Interventions for Insomnia

In this episode, we explore the potential of fish oil as an adjunct to cognitive–behavioral therapy for treating depression in youth. Can this combination enhance treatment outcomes, or is cognitive–behavioral therapy alone just as effective? Join us as we dive into this intriguing study.

Faculty: David Rosenberg, M.D.
Host: Richard Seeber, M.D.

• Learn more about our membership here
• Earn 0.5 CMEs: CAP Smart Takes Vol. 16
• Is Fish Oil Effective in Youth Depression?

In this episode, we explore the use of benzodiazepines and nonbenzodiazepine hypnotics for managing insomnia in major depressive disorder. How do these medications work, and what are the key considerations when prescribing them? Join us as we navigate the complexities of pharmacologic interventions for insomnia.

Faculty: Amit Chopra, M.D.
Host: Richard Seeber, M.D.

• Learn more about our memberships here
• Earn 1.25 CME: Navigating Insomnia in Major Depressive Disorder: Advances in Management
• Pharmacologic Interventions for Insomnia: Benzodiazepines and Non-Benzodiazepine Hypnotics

In this episode, we explore the safety of antipsychotics in patients with liver disease. How can psychiatrists navigate the risk–benefit balance when treating medically complex individuals? Dr. Sydney LeFay discusses key insights from a recent review article, guiding antipsychotic selection and monitoring.

Faculty: Sydney LeFay, D.O.
Host: Richard Seeber, M.D.

• Learn more about our membership here
• Earn 0.75 CMEs: Quick Take Vol. 56
• Antipsychotic Safety in Liver Disease

In this episode, we explore the complex relationship between insomnia and major depressive disorder. How does insomnia impact the course and treatment of depression? Join us as we dive into the neurobiology and clinical implications of this fascinating topic with expert Dr. Amit Chopra.

Faculty: Amit Chopra, M.D.
Host: Richard Seeber, M.D.

• Learn more about our memberships here
• Earn 1.25 CME: Navigating Insomnia in Major Depressive Disorder: Advances in Management
• Understanding the Relationship Between Insomnia Disorder and MDD

In this episode, we explore the long-term effects of ADHD medication use during pregnancy on children's development. Can continuing treatment pose risks, or is it safer than previously thought? Join us as we dive into a groundbreaking Danish study that sheds light on this critical question.

Faculty: David Rosenberg, M.D.
Host: Richard Seeber, M.D.

• Learn more about our membership here
• Earn 0.5 CMEs: CAP Smart Takes Vol. 16
• In Utero Exposure to ADHD Medication and Long-Term Offspring Outcomes

In this episode, we explore the growing evidence for nonpharmacologic therapies in managing fibromyalgia symptoms. Could a combination of exercise, cognitive–behavioral therapy, and integrative approaches, like acupuncture or yoga, be the key to better outcomes for patients resistant to traditional treatments?

Faculty: Daniel Clauw, M.D.
Host: Richard Seeber, M.D.

• Learn more about our memberships here
• Earn 0.75 CME: Nociplastic Pain Syndromes: Focus on Fibromyalgia
• Nonpharmacologic Therapies for Fibromyalgia

In this episode, the editorial team of the Psychopharmacology Institute discusses 3 important topics presented at the APA Annual Meeting: Prescribing psychiatric medications during pregnancy, recent advances in clozapine treatment, and managing eating disorders, namely anorexia nervosa and bulimia nervosa. The episode covers the safety and dose adjustments for medications like SSRIs, lamotrigine, and lithium during pregnancy; early initiation and monitoring of clozapine; and effective treatments, including psychotherapy, olanzapine, and fluoxetine for eating disorders.

Hosts: Flavio Guzman, M.D., Paz Badia, M.D., and Lorena Rodriguez, M.D.